Lamotrigine Milpharm

Lamotrigine, the active ingredient in Lamotrigine Milpharm, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed for the treatment of epilepsy, including partial and generalized tonic‑clonic seizures, and for maintenance therapy in bipolar disorder in adult patients and adolescents. It is available in several dose strengths for individualized titration.

GNH USA supplies Lamotrigine Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides reliable logistics to ensure timely delivery to healthcare providers across Europe, Asia, Africa and the Americas.

Lamotrigine is used in neurological and psychiatric conditions that involve abnormal neuronal excitability.

- Epilepsy (partial seizures): Reduces frequency and severity of partial onset seizures. - Epilepsy (generalized tonic‑clonic seizures): Controls generalized tonic‑clonic seizure activity. - Bipolar disorder (maintenance treatment): Helps prevent recurrence of mood episodes in bipolar I disorder.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as agranulocytosis - Severe skin reactions (DRESS) - Hepatic failure

When prescribing lamotrigine, clinicians should observe several safety measures.

- Monitor for skin reactions: Discontinue immediately if any rash or hypersensitivity signs appear. - Avoid abrupt discontinuation: Gradually taper to reduce risk of seizure worsening. - Use caution in hepatic impairment: Dose may need adjustment and liver function monitoring. - Consider pregnancy risks: Category unknown; evaluate benefits versus potential fetal risks. - Review concomitant valproate therapy: May require dose reduction due to increased lamotrigine levels. - Store at room temperature: Keep in original packaging, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma levels or increase toxicity risk.

Major Interactions (Avoid): - Valproic acid: Increases lamotrigine plasma concentrations, raising risk of toxicity. - Carbamazepine, phenytoin, phenobarbital: Decrease lamotrigine levels, potentially reducing efficacy. - Oral contraceptives: Induce lamotrigine clearance, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Other enzyme inducers (e.g., rifampicin): May lower lamotrigine exposure. - Serotonergic agents (e.g., SSRIs, SNRIs): Potential for increased risk of serotonin syndrome. - Antidepressants with hepatic metabolism: May modestly affect lamotrigine levels.